STERIS /STE
13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX
About STERIS
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.
Ticker
STE
Sector
Healthcare
Trading on
NYSE
Industry
Health Care Equipment and Supplies
Headquarters
Mentor, United States
Employees
18,000
Website
www.steris.com
STERIS Metrics
BasicAdvanced
$22B
Market cap
57.36
P/E ratio
$3.81
EPS
0.85
Beta
$2.03
Dividend rate
0.93%
Dividend yield
Price and volume
Market cap
$22B
Beta
0.85
Dividend rate
$2.03
Financial strength
Current ratio
3.081
Quick ratio
1.305
Long term debt to equity
49.406
Total debt to equity
49.406
Dividend payout ratio (TTM)
53.03%
Interest coverage (TTM)
6.28%
Management effectiveness
Return on assets (TTM)
5.09%
Return on equity (TTM)
8.92%
Valuation
Price to earnings (TTM)
57.36
Price to revenue (TTM)
4.2
Price to book
3.42
Price to tangible book (TTM)
192.19
Price to free cash flow (TTM)
35.19
Dividend yield (TTM)
0.93%
Growth
Revenue change (TTM)
3.65%
Earnings per share change (TTM)
255.78%
3-year revenue growth
18.25%
3-year earnings per share growth
-6.32%
3-year dividend per share growth
8.94%
What the Analysts think about STERIS
Analyst Ratings
Majority rating from 8 analysts.
STERIS Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q4 24
QoQ growth
Revenue
$1.1B
-20.03%
Net income
-$1.3M
-100.92%
Profit margin
-0.11%
-101.09%
STERIS Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q1 24
Q2 24
Q3 24
Q4 24
Q1 25
Actual
$2.00
$2.03
$2.22
$2.58
-
Expected
$1.87
$2.00
$2.17
$2.35
$2.01
Surprise
7.10%
1.31%
2.34%
9.79%
-
STERIS News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market openNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for STERIS stock?
STERIS (STE) has a market cap of $22B as of July 03, 2024.
What is the P/E ratio for STERIS stock?
The price to earnings (P/E) ratio for STERIS (STE) stock is 57.36 as of July 03, 2024.
Does STERIS stock pay dividends?
Yes, the STERIS (STE) stock pays dividends to shareholders. As of July 03, 2024, the dividend rate is $2.03 and the yield is 0.93%. STERIS has a payout ratio of 53.03% on a trailing twelve-month basis.
When is the next STERIS dividend payment date?
The next STERIS (STE) dividend payment date is unconfirmed.
What is the beta indicator for STERIS ?
STERIS (STE) has a beta rating of 0.85. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell STERIS stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.